Symmetry Investments LP Repligen Corp Put Options Transaction History
Symmetry Investments LP
- $844 Million
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RGEN
# of Institutions
495Shares Held
57.6MCall Options Held
75.6KPut Options Held
521K-
Black Rock Inc. New York, NY7.57MShares$942 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.57MShares$941 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$632 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$210 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.67MShares$208 Million0.04% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $6.9B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....